cas 5975-12-2|| where to buy 2,4-Dichloro-3-nitropyridine

Nom du produit:2,4-Dichloro-3-nitropyridine

IUPAC Name:2,4-dichloro-3-nitropyridine

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM120502-1000g	in stock	ǪŌĲ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 5975-12-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:5975-12-2; Formule moléculaire:C5H2Cl2N2O2; Point de fusion:-; Code SMILES:O=[N+](C1=C(Cl)C=CN=C1Cl)[O-]; Densité:

: Numéro de catalogue:CM120502; Poids moléculaire:192.98; Point d'ébullition:; N° Mdl:MFCD09261088; Stockage:

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: Tolebrutinib; Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis(nrSPMS).
Tolebrutinib is an investigational, oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase (BTK) inhibitor that achieves CSF concentrations predicted to modulate B lymphocytes and disease-associated microglia.